Harrison Ball

3.3k total citations · 1 hit paper
47 papers, 2.4k citations indexed

About

Harrison Ball is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Harrison Ball has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Reproductive Medicine, 19 papers in Obstetrics and Gynecology and 12 papers in Surgery. Recurrent topics in Harrison Ball's work include Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (16 papers) and Cervical Cancer and HPV Research (8 papers). Harrison Ball is often cited by papers focused on Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (16 papers) and Cervical Cancer and HPV Research (8 papers). Harrison Ball collaborates with scholars based in United States and Canada. Harrison Ball's co-authors include John A. Blessing, Jonathan S. Berek, Mark F. Brady, J.T. Thigpen, R J Barrett, John A. Blessing, Samuel S. Lentz, P. Hanjani, J A Blessing and Stephen Williams and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Harrison Ball

46 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1994 502 citations Mark F. Brady, Harrison Ball et al. American Journal of Obstetrics and Gynecology profile →

Peers

Countries citing papers authored by Harrison Ball

Since Specialization

Citations

This map shows the geographic impact of Harrison Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harrison Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harrison Ball more than expected).

Fields of papers citing papers by Harrison Ball

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harrison Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harrison Ball. The network helps show where Harrison Ball may publish in the future.

Co-authorship network of co-authors of Harrison Ball

This figure shows the co-authorship network connecting the top 25 collaborators of Harrison Ball. A scholar is included among the top collaborators of Harrison Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harrison Ball. Harrison Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 5592: Expansion and characterization on ALK positive NSCLC circulating tumor cells isolated using a size based inertial microfluidic Labyrinth device 2023 ·Cancer Research ·Yuru Chen, Shamileh Fouladdel, Harrison Ball, Cheng Xu, Liwei Bao, (unknown), Albert Liu, (unknown), (unknown), (unknown), Aaron M. Udager, Angel Qin, Sofía D. Merajver, Sunitha Nagrath	1
2	Abstract 5581: Single-cell genomic analysis of patient-derived circulating tumor cells in pancreatic cancer 2023 ·Cancer Research ·Harrison Ball, (unknown), Sarah Owen, (unknown), Valerie Gunchick, Evan T. Keller, Vaibhav Sahai, Sunitha Nagrath	1
3	Circulating tumor cells in precision medicine: challenges and opportunities 2022 ·Trends in Pharmacological Sciences ·(unknown), Harrison Ball, (unknown), Deepak Nagrath, Sunitha Nagrath	63
4	Primary angiosarcoma of the ovary: A case report of Stage I disease 2005 ·Gynecologic Oncology ·(unknown), Cuizhen Li, (unknown), Susan Zweizig, Harrison Ball	21
5	Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study 1999 ·Gynecologic Oncology ·Gregory P. Sutton, John A. Blessing, Harrison Ball	57
6	A Phase II Trial of Amonafide in Patients With Mixed Mesodermal Tumors of the Uterus 1998 ·American Journal of Clinical Oncology ·Robert F. Asbury, John A. Blessing, Edward Podczaski, Harrison Ball	7
7	High-Dose Megestrol Acetate in the Treatment of Patients With Ovarian Cancer Who Have Undergone Previous Treatment 1998 ·American Journal of Clinical Oncology ·Peter H. Wiernik, Edward S. Greenwald, Harrison Ball, James A. Young, Steven E. Vogl	14
8	A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study 1996 ·Gynecologic Oncology ·Harrison Ball, John A. Blessing, Samuel S. Lentz, (unknown)	178
9	Prognostic factors for local and distant recurrence in Stage I and II cervical carcinoma 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Maria Werner‐Wasik, Christopher H. Schmid, (unknown), Harrison Ball, Donna Smith, Hywel Madoc‐Jones	64
10	Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. 1995 ·Journal of Clinical Oncology ·William P. McGuire, William J. Hoskins, Mark F. Brady, Howard D. Homesley, William T. Creasman, M L Berman, Harrison Ball, Jonathan S. Berek, Jason Woodward	149
11	Salvage Therapy for Recurrent and Refractory Ovarian Cancer with High-Dose Chemotherapy and Autologous Bone Marrow Support: A Gynecologic Oncology Group Pilot Study 1994 ·Gynecologic Oncology ·E. Randolph Broun, Jerome L. Belinson, Jonathan S. Berek, David E. McIntosh, David D. Hurd, Harrison Ball, Stephen D. Williams	15
12	Molecular Genetic Changes Associated with Ovarian Cancer 1994 ·Gynecologic Oncology ·Jeffrey N. Weitzel, (unknown), (unknown), Annekathryn Goodman, Homa Safaii, Harrison Ball	32
13	Second-Look Laparotomy in Ovarian Germ Cell Tumors: The Gynecologic Oncology Group Experience 1994 ·Gynecologic Oncology ·Stephen D. Williams, John A. Blessing, Philip J. DiSaia, Francis J. Major, Harrison Ball, Shu‐Yuan Liao	58
14	Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. 1994 ·Journal of Clinical Oncology ·Stephen Williams, J A Blessing, S Y Liao, Harrison Ball, P. Hanjani	222
15	The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma breakdown → 1994 ·American Journal of Obstetrics and Gynecology ·(unknown), (unknown), Mark F. Brady, (unknown), (unknown), (unknown), Harrison Ball, Jonathan S. Berek	502
16	Ultrasound for diagnosing and preventing malplacement of intrauterine tandems. 1990 ·PubMed ·C.O. Granai, Frederick Doherty, (unknown), Harrison Ball, (unknown), Stephen L. Curry	36
17	Phase II Study of Vinblastine in Previously Treated Squamous Carcinoma of the Cervix 1990 ·American Journal of Clinical Oncology ·Gregory P. Sutton, John A. Blessing, Willard A. Barnes, Harrison Ball	11
18	Stage II carcinoma of the cervix: analysis of the value of pretreatment extraperitoneal lymph node sampling and adjunctive surgery following irradiation 1990 ·Radiotherapy and Oncology ·Olubunmi K. Abayomi, Mison Chun, Harrison Ball	1
19	A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix 1989 ·Investigational New Drugs ·Robert E. Slayton, John A. Blessing, Mark A. Rettenmaier, Harrison Ball	5
20	A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix 1989 ·Gynecologic Oncology ·Philip Bonomi, John A. Blessing, Harrison Ball, P. Hanjani, P.J. DiSaia	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact